RESEARCH TRIANGLE PARK, N.C. & SHERBROOKE, Quebec--(BUSINESS WIRE)--May 17, 2006--Tranzyme Pharma, a leading biopharmaceutical company developing small molecule therapeutics for the treatment of gastrointestinal (GI) and metabolic diseases, announced today that its Vice President of Drug Discovery, Dr. Graeme Fraser, will present results from preclinical proof-of-concept studies on two of the Company’s novel development candidates at the upcoming 2006 Digestive Disease Week to be held at Los Angeles, CA. The new data will be highlighted in two oral presentations to be given on Sunday, May 21.
